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Abstract
Escherichia coli Nissle 1917 (EcN) is among the best characterised probiotics, with a prov-
en clinical impact in a range of conditions. Despite this, the mechanisms underlying these
"probiotic effects" are not clearly defined. Here we applied random transposon mutagenesis
to identify genes relevant to the interaction of EcN with intestinal epithelial cells. This dem-
onstrated mutants disrupted in the kfiB gene, of the K5 capsule biosynthesis cluster, to be
significantly enhanced in attachment to Caco-2 cells. However, this phenotype was distinct
from that previously reported for EcN K5 deficient mutants (kfiC null mutants), prompting us
to explore further the role of kfiB in EcN:Caco-2 interaction. Isogenic mutants with deletions
in kfiB (EcNΔkfiB), or the more extensively characterised K5 capsule biosynthesis gene
kfiC (EcNΔkfiC), were both shown to be capsule deficient, but displayed divergent pheno-
types with regard to impact on Caco-2 cells. Compared with EcNΔkfiC and the EcN wild-
type, EcNΔkfiB exhibited significantly greater attachment to Caco-2 cells, as well as apopto-
tic and cytotoxic effects. In contrast, EcNΔkfiC was comparable to the wild-type in these as-
says, but was shown to induce significantly greater COX-2 expression in Caco-2 cells.
Distinct differences were also apparent in the pervading cell morphology and cellular aggre-
gation between mutants. Overall, these observations reinforce the importance of the EcN
K5 capsule in host-EcN interactions, but demonstrate that loss of distinct genes in the K5
pathway can modulate the impact of EcN on epithelial cell health.
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Introduction
Due to the intimate role of the gut microbiome in human health and disease processes, this
predominantly bacterial community is increasingly viewed as an important target for the devel-
opment of novel approaches to diagnose, prevent, or treat a wide range of disorders [1–4]. In
this context, probiotics are among the most promising tools for manipulation of the gut micro-
biome, and have been defined as “live microorganisms which when administered in adequate
amounts confer a health benefit on the host” [5]. The majority of probiotics are Gram-positive
bacterial species, and considerable evidence is accumulating regarding the efficacy of these or-
ganisms in treating or preventing a variety of gastrointestinal (GI) diseases, and potentially also
extra-intestinal disorders [1–4].
Among the probiotics currently available, Escherichia coliNissle 1917 (EcN; serotype O6:
K5:H1) is of particular interest. Not only is this one of the most extensively characterized pro-
biotic organisms (in terms of phenotype, genotype, and clinical efficacy), but is currently the
only Gram-negative species in use [6]. EcN was first isolated from the faeces of a World War I
soldier who, in contrast to comrades in his trench, was not affected by an outbreak of dysentery
[7]. This gastroprotective strain is the active component of Mutaflor (Ardeypharm GmbH,
Herdecke, Germany), a microbial drug that is marketed and used in several countries. Clinical
trials have shown EcN to be effective for maintaining remission of ulcerative colitis (UC) [8–
11], stimulation of the immune system in premature infants [12], treatment of infectious diar-
rhoea [13], and protection of human intestinal epithelial cells (IECs) against pathogens [14,
15]. These benefits are largely attributed to the immuno-modulatory effects elicited by EcN,
which encompass both innate and adaptive elements of the immune system. For example, colo-
nisation with EcN has been indicated to alter the host cytokine profile, and also chemokine
production in cultured IECs [16–19]; stimulate the production of mucosal peptide based de-
fences [20]; influence the clonal expansion of T-Cell populations, and modulate antibody re-
sponses [12, 21, 22]. Notably, the modulation of T-cell functions mediated by EcN may also
extend to γδ T-cells, potentially enabling EcN to coordinate modulation of both innate and
adaptive responses [22]. EcN has also been indicated to alter COX-2 expression in intestinal
epithelial cells [23], which is an important target in the treatment or prevention of several GI
diseases including IBD and colorectal cancer [24–27].
Although most closely related to uropathogenic strains of E. coli (UPEC), EcN is considered
non-pathogenic. Genomic characterisation has highlighted the absence of genes encoding the
typical UPEC virulence factors, but the retention or accumulation of factors proposed to facilitate
general adaptability, colonisation of the GI tract, and the probiotic effects of EcN [28, 29]. These
include a range of surface associated structures that are likely to provide the primary interface be-
tween host and microbe in the GI tract, such as flagella, fimbriae, a special truncated lipopolysac-
charide (LPS) variant, and a K5 type polysaccharide capsule [6, 29–31]. In particular, structures
such as flagellin, peptidoglycan and LPS, are recognised by immune regulating Toll-like receptors
(TLRS) expressed by IECs, which have been established as key routes of host-microbe communi-
cation in the gut, with TLR signalling integral to epithelial homoeostasis and defence [32–34]. Sig-
naling by several TLRs is known to be modulated either directly or indirectly by EcN derived
ligands [6, 17–20, 30, 35], which include surface associated structures absent in most or all other
probiotic organisms. The K5 capsule produced by EcN in particular is notable in this context, and
although not a ligand for known TLRs, the EcN capsule has been implicated in the interaction of
this organism with IECs, and impact on chemokine expression and TLR signalling [18,19].
Nevertheless, as with other probiotics, the detailed mechanisms underlying the clinical ef-
fectiveness of EcN remain poorly understood overall, with a greater comprehension required
to fully realise the potential of this important probiotic species. Here we describe the
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application of random transposon mutagenesis to identify genes and surface structures in-
volved in the interaction of EcN with human intestinal epithelial cells, and provide new insight
into the mechanisms through which EcN interacts with epithelial cells.
Results
Isolation and genetic characterisation of EcN mutants with disruptions in
genes related to cell surface structures
Because cell surface structures are a primary point of contact between EcN and IECs, and pro-
cesses such as biofilm formation and attachment to abiotic surfaces also depends on many of
the same structures, we reasoned that selection of mutants with alterations in biofilm forma-
tion would enrich for those defective in cell surface associated features also likely to be involved
in EcN-IEC interaction. Therefore, we initially subjected a total of 4,116 EcN mini-Tn5mu-
tants to a preliminary high throughput screen for alterations in biofilm formation (both en-
hancements and reductions), in order to enrich for mutants attenuated in cell surface features.
In this precursor biofilm screen 21 mutants were found to be significantly different in their
ability to form biofilms as compared to the EcN wild-type (EcNWT), but unaltered in general
growth rate. The majority of these (n = 15) exhibited a biofilm formation enhanced (BFE) phe-
notype, whereas six exhibited biofilm formation deficient (BFD) phenotype as compared to the
WT (Table 1). Identities of genes disrupted in these mutants indicated that the majority were
associated with synthesis of cell surface structures, or aspects of cell envelope biogenesis, previ-
ously linked to host-IEC interaction or intestinal colonisation (Table 1; [18, 35, 37–40]). A sub-
set of 6 mutants disrupted in genes predicted to encode for cell surface structures, and
encompassing both BFD and BFE phenotypes, were subsequently selected for further charac-
terisation of their interaction with cultured IECs.
Adherence of EcN cell surface structure mutants to Caco-2 cells
The ability of selected mutants to attach to intestinal epithelial cells was examined using an in
vitro co-culture model, in which Caco-2 cells were exposed to EcN Tn mutants at a multiplicity
of infection (MOI) of 1:1 (bacteria:Caco-2). Overall, the levels of adherence observed in these
experiments showed no relationship with abilities to form biofilms on abiotic surfaces, but
most mutants tested were observed to differ in levels of adherence compared to wild-type cells
(Fig. 1). The lowest levels of adherence to Caco-2 cells were noted for mutant JNBF2, disrupted
in the fimD gene of the type 1 fimbrial biosynthesis pathway (Table 1), in keeping with the es-
tablished role of type 1 fimbriae in EcN host cell attachment [35]. In contrast, the greatest level
of adherence to Caco-2 cells was observed for mutant JNBF16 (Fig. 1). This mutant was found
to be disrupted in the kfiB gene, part of the K5 capsule biosynthesis gene cluster and vital for
K5 production, indicating JNBF16 to be capsule deficient ([29, 41, 42], S1 Fig; Fig. 1). This kfiB
mutant exhibited ~2.2-fold greater attachment to Caco-2 cells than the wild-type EcN. In con-
trast, it was notable that mutant JNBF17 was also disrupted in the kpsT gene associated with
K5 capsule synthesis, but exhibited no significant alterations in adherence to Caco-2 cells
(Table 1, S1 Fig). Since kpsT has previously been established to encode ABC transporter func-
tions vital for K5 production [41, 43], this pointed to a role for kfiB specifically in the JNBF16
phenotype, rather than loss of the K5 capsule in general.
Generation and characterisation of EcNΔkfiB and EcNΔkfiCmutants
The significant alterations in interaction of the JNBF16 mutant with Caco-2 cells was in con-
trast to previous reports of the interaction of capsule deficient EcN with Caco-2 cells, where no
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significant change in attachment was observed [18]. This prompted us to explore the role of
kfiB in further detail, through the construction of two isogenic knockout mutants in which ei-
ther kfiB (EcNΔkfiB) or the downstream kfiC gene (EcNΔkfiC) were deleted (S1 Fig). Attenua-
tion of capsule biosynthesis in both mutants was assessed using the bacteriophage FK5
sensitivity assay, in which loss of K5 capsule results in resistance to FK5 infection [18, 44].
Both EcNΔkfiB and EcNΔkfiC, as well as the K12 control strain MG1655 were resistant to
Table 1. Analysis of nucleotide sequence in EcNmutants with biofilm formationmutants.
Mutant a % of wild-type
bioﬁlm formation b
Phenotype c Putative function/product of disrupted gene d
JNBF1 36 (0.6) BFD EcN CCQ07028.1: Arginine/ornithine antiporter ArcD +
JNBF2 45 (0.5) BFD EcN CCQ07908.1: Type 1 ﬁmbriae anchoring protein FimD +
JNBF3 49 (0.3) BFD EcN CCQ05466.1: Flagellar hook-associated protein FliD +
JNBF4 53 (0.9) BFD EcN CCQ05486.1: Flagellar motor switch protein FliM +
JNBF5 55 (4.9) BFD EcN CCQ05465.1: Flagellar biosynthesis protein FliC +
JNBF6 55 (0.8) BFD EcN CCQ07955.1: Periplasmic thiol:disulﬁde interchange protein DsbA +
JNBF7 151 (3.6) BFE EcN CCQ06617.1: CidA-associated membrane protein CidB +
JNBF8 157 (2.4) BFE EcN CCQ05558.1: Integrase
JNBF9 157 (5.8) BFE EcN CCQ07966.1: Hypothetical protein.
JNBF10 162 (0.8) BFE ECN CCQ05175.1: Hypothetical protein. *Similar to inner membrane transport protein ydiN
from E. coli EPECa12 (1e-121, 200/225).
+
JNBF11 164 (7.5) BFE EcN CCQ05967.1: Hypothetical lipoprotein yghG precursor
JNBF12 170 (5.9) BFE EcN CCQ05908.1: Uncharacterised protein YggN. *Similar to hypothetical protein
ECG581_3391 from E. coli G58–1 (1e-67 105/105). Contains partial ansB/L-asparaginase II
conserved domains (PRK11096, 2.44e-04)
JNBF13 170 (3.2) BFE EcN CCQ05917.1: Putative inner membrane protein YqgA +
JNBF14 171 (5.1) BFE EcN CCQ05004.1: Chaperone HdeA
JNBF15 172 (2.5) BFE EcN CCQ06089.1: G:T/U mismatch-speciﬁc uracil/thymine DNA-glycosylase
JNBF16 179 (6.6) BFE EcN CCQ05952.1: KﬁB protein, from K5 biosynthesis gene cluster +
JNBF17 182 (4.8) BFE EcN CCQ05954.1: Polysialic acid transport ATP-binding protein KpsT, from K5 biosynthesis
gene cluster
+
JNBF18 188 (8.5) BFE EcN CCQ04927.1: Hypothetical protein. *Contains conserved domains from Type IV
secretion system components (COG 3157, 1.24e-44) and HNH endonucleases (cd00085,
9.37e-03).
+
JNBF19 194 (5.0) BFE EcN: CCQ04506.1: Signal transduction histidine-protein kinase BarA +
JNBF20 200 (2.7) BFE EcN CCQ07742.1: Probable transcriptional activator for leuABCD operon
JNBF21 222 (1.2) BFE Intergenic region: Tn inserted between Peptidyl-prolyl cis-trans isomerase PpiA precursor
(EcN CCQ04837.1) and TsgA protein homolog (EcN CCQ04838.1)—presumed to disrupt
promotor regions.
+
a Mutants in bold were selected for further characterisation (See Fig. 1 and associated text).
b Bioﬁlm formation was calculated as a % of the wild-type level quantiﬁed using CV staining assay. Results represent the mean of replicate experiments
(n = 3) and ﬁgures in parentheses show the standard error of the mean. All mutants shown were signiﬁcantly altered in bioﬁlm formation compared to the
wild-type (P < 0.05).
c BFD—bioﬁlm formation deﬁcient; BFE—bioﬁlm formation enhanced.
d Putative functions of disrupted genes were primarily assigned based on the correlation of sequences ﬂanking mini-Tn5 inserts to the EcN draft genome
sequence [28]. ~40 nt directly ﬂanking the transposon were mapped to EcN contigs.
* In cases where EcN genome annotations did not provide a clear indication of function, BlastX searches against the full nr dataset, and/or the conserved
domain database were used to infer function, with values in parentheses providing e-value and identity for these searches.
+ indicates genes predicted to be involved in synthesis of surface associated structures, broader aspects of cell envelop biogenesis, or associated with the
cell envelop.
doi:10.1371/journal.pone.0120430.t001
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phage FK5, confirming capsule synthesis was compromised in both mutants (Fig. 2a). The ex-
pression of other genes in the region 2 kfi sub-cluster were also tested in both EcNΔkfiB and
EcNΔkfiC using RT-PCR, and confirmed that gene deletions did not compromise expression
of other kfi genes in either mutant (Fig. 2b). The original enhanced biofilm formation pheno-
type on abiotic surfaces was retained by EcNΔkfiB, but despite the common attenuation in K5
capsule production, EcNΔkfiC exhibited no alteration in biofilm formation on abiotic surfaces
(Fig. 2c). EcNΔkfiB also exhibited significantly greater levels of adhesion to Caco-2 cells com-
pared with both the EcN wild-type and EcNΔkfiC (Fig. 2d), in keeping with results from exper-
iments with the original JNBF16 Tn mutant (Fig. 1). In contrast EcNΔkfiC exhibited levels of
adherence comparable to the wild-type (Fig. 2d).
Impact of EcNΔkfiB and EcNΔkfiC on Caco-2 cell health
Distinct differences between EcNΔkfiB and EcNΔkfiC were also observed when effects on cell
health were assessed. Compared to the EcNWT, EcNΔkfiB significantly increased activation of
caspase 3/7 (indicative of apoptosis), as well as release of lactate dehydrogenase (LDH) into the
medium (indicative of general cell damage; Fig. 3a, b). In contrast, EcNΔkfiC promoted no sig-
nificant changes in levels of caspase 3/7 activation, and although exposure resulted in a signifi-
cant increase in LDH release, this was considerably less pronounced than in cells exposed to
EcNΔkfiB (Fig. 3b). We also assessed the impact of these mutants on COX-2 protein expres-
sion, an important therapeutic target for probiotics in the GI tract. Compared to Caco-2 cells
treated with EcNWT or EcNΔkfiB, cells treated with EcNΔkfiC expressed significantly greater
levels of COX-2, which were comparable to those induced by the pro-inflammatory stimuli
used as positive controls (Salmonella LPS and human TNF-α; Fig. 3c). When Caco-2 cells
Fig 1. Adherence of EcNmini-Tn5mutants to Caco-2 cells. A subset of mutants recovered from biofilm
screens with disruptions in genes predicted to be involved in generation of surface tstructures, were
assessed for their ability to attach to Caco-2 cells in in vitro co-culture models. Caco-2 cell monolayers (~80%
confluence) were exposed to bacterial suspensions frommid-log-phase cultures at an MOI of 1:1 for 4 h at
37°C, 5% CO2. Genes disrupted in mutants tested are noted in parentheses and details can be found in
Table 1. Data are expressed as the mean of three replicates, and error bars show SE of the mean. Significant
differences between attachment of EcNWT and mutants is indicated by ** (P 0.01) or **** (P<0.0001).
doi:10.1371/journal.pone.0120430.g001
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treated with either EcNWT, EcNΔkfiB or EcNΔkfiC were examined microscopically, following
double staining of actin and nuclei (Phalloidin red and DAPI respectively), Caco-2 cells ex-
posed to EcNΔkfiB were observed to exhibit greater incidence of condensed chromatin and nu-
cleus defragmentation, as well as rearrangements in the actin cyctoskeleton. However, these
features were not evident in cells exposed to EcNWT or MG1655, and considerably less pro-
nounced in Caco-2 cells treated with EcNΔkfiC (Fig. 3d). Co-culture with supernatants from
EcNΔkfiB did not induce effects observed when cell suspensions were used in co-culture mod-
els, suggesting that bacterial contact was essential for the observed effects.
Assessment of EcN morphology and aggregation
Mutants lacking an outer polysaccharide capsule may also be altered in interactions between
bacterial cells, which could contribute to the observed phenotypes of capsule mutants and their
effects on Caco-2 cells. Therefore, using phase contrast microscopy, we examined cell suspen-
sions from cultures of EcNΔkfiB and EcNΔkfiC, and compared these with the EcNWT and the
kpsT::mini-Tn5mutant JNBF17. This latter mutant was isolated in original biofilm screens
(Table 1), and was included here since it is also blocked in K5 capsule production (based on re-
sistance to FK5—S1 Table), but at a distinct stage in K5 assembly compared to EcNΔkfiB and
EcNΔkfiC (mature polysaccharide transport to the cell surface in kpsT::mini-Tn5; S1 Fig). In all
Fig 2. Initial characterisation of kfiB and kfiC deletionmutants. Isogenic mutants deleted for the K5 capsule biosynthesis genes kfiB (EcNΔkfiB) or kfiC
(EcNΔkfiC) were assessed to confirm attenuation of capsule production, ensure gene deletions did not impact expression of downstream genes, and assess
impact on biofilm formation and Caco-2 adherence. A) Loss of capsule production was confirmed using theΦK5 bacteriophage sensitivity assay, in which
cells lacking a K5 capsule are resistant. Images show results from soft ager overlay plates for strains exposed to 106 to 104 pfu/ml of bacteriophage, in which
phage replication is manifest as plaques or clearing of the confluent bacterial growth. EcNWT—E. coli Nissle 1917 wild-type; MG1655—E. coli K12 control
strain naturally lacking a K5 capsule; EcNΔkfiB—EcN kfiB deletion mutant; EcNΔkfiC—EcN kfiC deletion mutant.B) Expression of associated genes in the
kfi gene cluster were assessed in deletion mutants using RT-PCR, and figures indicate gene found to be active in each mutant.C) The impact of kfiB or kfiC
gene deletion on the ability of EcN to form biofilms on abiotic surfaces was assessed using the CV biofilm assay, as originally used to screen mini-Tn5
mutants, and compared to the levels of WT biofilm formation. Data shows absorbance readings obtained following elution of CV stain from biofilms.D) The
impact of kfiB or kfiC gene deletion on the ability of EcN to adhere to cultured Caco-2 cells was assessed using a co-culture system as for Fig. 1. EcNWT—E.
coli Nissle 1917 wild-type; EcNΔkfiB—EcN kfiB deletion mutant; EcNΔkfiC—EcN kfiC deletion mutant. All figures show the mean of three replicate
experiments, and error bars show SE of the mean. Significant differences betweenWT EcN and mutants is indicated by ** (P 0.01) or **** (P<0.0001).
doi:10.1371/journal.pone.0120430.g002
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mutant strains distinct differences compared to the wild-type were noted in terms of cell mor-
phology and the presence of cellular aggregates. However, each mutant also displayed a distinct
phenotype when compared with all others (Fig. 4). Wild-type cultures were found to be com-
posed predominantly of short vegetative cells, with only few small aggregates observed, but a
Fig 3. Impact of E. coliNissle capsule deficient mutants on Caco-2 cell health.Owing to differences in adherence to Caco-2 cells, the impact of kfiB or
kfiC gene deletion, and the K5 capsule on cell health was investigated using the co-culture system.A) The impact of capsule deficient mutants and wild-type
strains on apoptosis was assessed by measuring caspase 3/7 activity after exposure to E. coli strains (MOI 10:1, bacteria:Caco-2) using the Caspase-Glo 3/
7 luminescent assay. Cells treated with camptothecin (0.1 M) served as positive controls for apoptosis. Activity measured in relative light units (RLUs) and
expressed as a % difference in activity observed in untreated Caco-2 controls. B)Cytotoxic effects of capsule deficient mutants were assessed by measuring
the release of Lactate Dehydrogenase (LDH) from Caco-2 cells, after exposure to E. coli strains (MOI 10:1). LDH in media was quantified using the CytoTox
96 colorimetric assay (OD 490nm), and readings normalised to values obtained from complete lysates of untreated Caco-2 cells (100% LDH). Differences in
LDH release between treatments was expressed as the % difference in normalised LDH release observed in media from untreated Caco-2 cells.C) The
expression of COX-2 in lysates from treated or untreated Caco-2 cells was determined byWestern blotting using anti-COX-2 antibody, followed by
densitometry of developed films. Caco-2 cells were treated with E. coli cells frommid-log phase cultures at an MOI of 10:1, LPS, or human TNF-α; the latter
treatments serving as positive controls for COX-2 expression. Quantities of COX-2 protein were normalised to densitometry readings from GAPDH. The
chart provides normalised COX-2 densitometry readings, as the mean of three independent experiments, and error bars SE of the mean. Images show
example blots for COX-2 and GAPDH.D) Changes in the actin cytoskeleton and nuclear morphology were assessed by double staining of treated and
control cells with phalloidin red (F-actin) and DAPI (DNA). Stained cells were viewed using confocal laser microscopy, and images shown are representative
of replicate experiments. Images were processed only to normalise brightness, contrast, and saturation. Data represent the means of 4 replicate
experiments, and error bars show SE of the mean. EcNWT—E. coli Nissle 1917 wild-type; MG1655—E. coli K12 control strain naturally lacking a K5
capsule; EcNΔkfiB—EcN kfiB deletion mutant; EcNΔkfiC—EcN kfiC deletion mutant; Cmpt—Camptothecin (0.1 M). Significant differences to untreated
controls are indicate by: * (P 0.05); ** (P 0.01); *** (P<0.001); **** (P<0.0001).
doi:10.1371/journal.pone.0120430.g003
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consistent low level of highly elongated cell forms were present (Fig. 4). In the JNBF17 kpsT
mutant, the incidence of elongated cells was considerably greater, and these were frequently ob-
served to form large, seemingly loosely associated aggregates (Fig. 4). In contrast, both EcNΔk-
fiB and EcNΔkfiC cultures were characterised by a complete absence of elongated cell forms
and were manifest as very short vegetative cells. However, in contrast to EcNΔkfiC, cells from
EcNΔkfiB were found to frequently form large aggregates, apparently with tight association be-
tween participating cells in many instances (Fig. 4).
Discussion
In this study we applied random transposon mutagenesis to identify genes relevant to EcN-IEC
interaction. This strategy was selected as it is not influenced by existing information, and
makes no prior assumptions regarding the involvement of particular genes in a given trait or
process. This approach identified the kfiB gene, and by inference K5 capsule biosynthesis (S1
Fig), to be important for EcN interaction with Caco-2 cells. Although the role of the K5 capsule
in EcN-IEC interaction has been previously investigated, these studies utilised mutants decap-
sulated via deletion of the kfiC gene, and the increased adherence displayed by the JNBF16 kfiB
mutant is in stark contrast to findings from these previous studies, which showed no alteration
in adherence to Caco-2 cells in kfiCmutants [18, 19]. Characterisation of a markerless mutant
deleted in kifB (EcNΔkfiB) supported results obtained with the initial JNBF16 mini-Tn5 kfiB
mutant, eliminating the possibility of factors relating to Tn mutagenesis to have led to a spuri-
ous phenotype in this mutant, and confirmed a role for kfiB in EcN adherence to Caco-2 cells.
However, since the kfiB product presently has no clearly defined role in K5 capsule biosyn-
thesis, and loss of K5 capsule had not previously been associated with the JNBF16 phenotype in
EcN, we also constructed an isogenic mutant deleted in the downstream kfiC gene (EcNΔkfiC)
as a comparator. In contrast to kfiB, the function of kfiC in capsule formation has been clearly
established, and loss of this glycolsyltransferase blocks synthesis of capsule precursors in the cell
cytoplasm, and ultimately assembly of the K5 capsule [18, 36]. Although the abolition of capsule
biosynthesis through deletion of closely related genes in the K5 pathway would be expected to
yield mutants with comparable phenotypes, and both EcNΔkfiB and EcNΔkfiC were indicated
to be capsule deficient in theFK5 bacteriophage assay, the phenotypes of these mutants were
distinct in almost all other assays (Summarised in S1 Table). Collectively, our data suggest that
loss of distinct K5 kfi genes may result in mutants with differing impacts on Caco-2 cells in co-
culture experiments. More specifically, we found that loss of kfiC leads to increased COX-2 ex-
pression in epithelial cells treated with this EcN mutant, while the loss of kfiB leads to increased
adherence, cytotoxicity, and induction of apoptosis (S1 Table).
The reasons for the differing impact of EcNΔkfiC and EcNΔkfiB on Caco-2 cells is currently
unclear, but may relate to wider effects on the complex protein-protein interactions underlying
K5 polysaccharide formation, as well as the loss of specific functions encoded by disrupted
genes. The K5 polysaccharide precursors are synthesised by the glycosyl transferases encoded
by kfiA and kfiC, which work in a coordinated fashion to link repeating units of GlcNAc (KfiA)
and GlcA (KfiC) from UDP sugar precursors; with KfiD providing substrates for KfiA through
isomerisation of UDP-Glc to UDP-GlcA, [S1 Fig; Reviewed in Whitfield [41], Corbett and
Roberts [45], Whitfield and Roberts [46]]. This process also requires the formation of KfiABC
membrane associated complexes, for the coordinated enzyme activity necessary for K5 precur-
sor production and export (S1 Fig; [36, 44, 47]). Of particular relevance to our observations are
findings that loss of KfiB prevents membrane localisation of KfiC, but not of KfiA [44]. In con-
trast, loss of KfiC abolishes the localisation of KfiA as well as KfiB [44]. This hierarchical inter-
action of Kfi proteins, and the associated model for K5 biosynthesis, also predicts EcNΔkfiB
E. coli Nissle 1917 K5 Capsule and EcN-Intestinal Cell Interaction
PLOS ONE | DOI:10.1371/journal.pone.0120430 March 19, 2015 8 / 19
mutants to retain KfiA activity but exhibit significant reduction or loss of KfiC activity, due to
abolished membrane localisation of this protein. In contrast, EcNΔkfiC would be predicted to
exhibit complete disruption of the K5 polysaccharide biosynthetic complex, since the deletion
of kfiC also leads to abolished membrane targeting in KfiA and KfiB [44].
Thus, it may be hypothesised that EcNΔkfiC could be subjected to a more complete disruption
of the K5 biosynthesis machinery, while EcNΔkfiBmay retain the capacity for reduced or aberrant
K5 precursor synthesis. This in turn raises the possibility that the divergent phenotypes observed
in these mutants arise from distinct differences in the assembly of surface structures related to
capsule biosynthesis. Notably, the current model of K5 biosynthesis described above predicts
EcNΔkfiB to still be theoretically capable of polymer synthesis, albeit at greatly reduced efficiency,
since the key glycosyl transferases (KfiA, KfiC) as well as UDP-glucose dehydrogenase KfiD are
still generated. Available evidence also suggests the K antigen export machinery (KpsMTDE;
S1 Fig) does not exhibit specificity for the polysaccharide chain, and is suggested to instead be spe-
cific for the kdo lipid modification [41], an aspect predicted to be unaffected in EcNΔkfiB or
EcNΔkfiC, and permissive of the potential for altered capsule components to be exported.
Although the synthesis of partial or aberrant K5 structures through loss of specific genes has
not previously been reported in such mutants, it is notable that many studies seeking to identify
and characterise genes essential for K5 biosynthesis have used resistance to the FK5 bacterio-
phage as a sole indicator of capsule loss [18, 19, 36, 44]; as has also been deployed in the present
Fig 4. Cell morphology and formation of aggregates in EcNwild-type and K5 capsulemutants. The potential for alterations in cell-cell interaction, and
the general cell morphology of EcNWT and capsule mutants was examined by phase contrast microscopy. 16h cultures were examined directly by phase
contrast microscopy, to assess cell morphology and the potential for cellular aggregation in EcNWT and capsule mutants. 9 fields of view were selected at
random for each slide examined, and subsequently reviewed as a collection to identify the pervading features. Images provide representative examples from
assessment of each strain. EcNWT—E. coli Nissle 1917 wild-type; KpsT-Tn5—EcN JNBF17 mini-Tn5 mutant disrupted in the K5 kpsT gene (Table 1);
EcNΔkfiB—EcN kfiB deletion mutant; EcNΔkfiC—EcN kfiC deletion mutant. Images are at 40× magnification and represent entire fields of view.
doi:10.1371/journal.pone.0120430.g004
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study. However, while resistance to FK5 is generally taken to be synonymous with a complete
absence of any K5 capsule structure, this does not preclude the assembly of a reduced capsule
structure, or the decoration of the cell surface with aberrant or partial K5 components. Studies
of capsule biosynthesis in the related K1 system (also group 2 capsular polysaccharides), and
the interaction of associated phage have demonstrated that K1 capsules with altered structure
may be produced but are resistant to phage K1 infection [48]. Furthermore, alterations in the
overall level of capsule production has also been found to influence phage infection in K1
strains, with mutants that exhibit structurally normal but reduced capsule production resistant
to phage infection [49].
Therefore, while the FK5 assay can provide a gross indication of perturbation in capsule
biosynthesis or assembly, it is unlikely to provide insight into more subtle alterations in surface
features that may be manifest in the K5 mutants studied here, such as reduced levels of K5 syn-
thesis, or the presentation of structurally abnormal capsule components on the cell surface.
Such differences could lead to the distinct phenotypes displayed by these mutants with respect
to biofilm formation and interaction with Caco-2 cells, yet would be in keeping with a common
phenotype in FK5 assays. When the data from K5 deficient mutants generated in this study
are considered collectively, and with respect to the potential limits of the FK5 assay in resolv-
ing the finer detail of capsule attenuation, the most parsimonious explanation for the divergent
phenotypes would seem to be the continued production of at least some K5 associated factors
in one or both of these mutants (S1 Table).
The potential for differences in the specific level or nature of K5 decapsulation in EcNΔkfiB
or EcNΔkfiC, also raises the possibility for involvement of other cell surface moieties in the im-
pact of these mutants on cultured epithelial cells. In terms of the EcNΔkfiB phenotype, factors
that promote auto-aggregation and biofilm formation in E. coli, would be prime candidates.
These include the Ag43 and AidA auto-transporter adhesins found in numerous strains of
E. coli, and for which homologues have been identified in the EcN genome [29, 50, 51]. This
theory is further supported by studies demonstrating the expression of a colanic acid capsule,
or K5 capsule, to produce a masking effect for auto-transporter adhesins like Ag43 and AidA
in some strains, effectively shielding these surface factors, and blocking their contribution to
biofilm formation as well as adherence to cultured human cells [50, 52].
In this scenario, the increased adherence of EcNΔkfiB to Caco-2 cells may be the result of en-
hanced EcN auto-aggregation and self-recognition, with attached EcNΔkfiB cells acting as foci
for further attachment and accumulation of planktonic EcN. The elevated biofilm formation
ability, increased formation of cellular aggregates, and enhanced attachment to host cells evi-
dent in the EcNΔkfiB, is congruent with this hypothesis, as well as the lack of activity observed
from cell free supernatants. In contrast, the phenotype of the kpsT::mini-Tn5 mutant (JNBF17;
Table 1, S1 Fig) would seem to only partially support this unmasking and auto-aggregation hy-
pothesis. KpsT encodes for a component of the K5 polysaccharide transport machinery, and
mutations in this gene have been shown to result in intra-cellular accumulation of polysaccha-
ride capsule precursors and lack of detectable capsule expression [43]. Therefore, if unshielded
surface proteins were a factor in the EcNΔkfiB phenotype, the JNBF17 kpsT::mini-Tn5 mutant
would be expected to exhibit a comparable behaviour in the same assays. However, while
JNBF17 showed an increase in biofilm formation, cellular aggregation, and was also resistant to
the K5 bacteriophage, this did not translate to significant increases in adherence to Caco-2 cells.
These results do not preclude EcNΔkfiB decapsulation from promoting auto-aggregation,
which is still supported by the JNBF17 phenotype and other data, but indicates the requirement
for additional factors in Caco-2 cell adherence specifically. The intracellular location of KpsT
precludes a direct role for this protein in adherence (S1 Fig), again indicating the adherent phe-
notype of EcNΔkfiB is mediated by factors, presumably related to K5 synthesis, that are still
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exported in this mutant. This is also consistent with the theoretical impact of kfiC or kfiB dele-
tion on assembly of the biosynthetic machinery, and the prediction of a more substantive im-
pact from loss of kfiC. Alternatively, the potential for the alterations in JNBF17 cell
morphology to play a role in the lack of increased adherence to Caco-2 cells cannot be fully ex-
cluded, but since JNBF17 still retained levels of adherence comparable to the WT it seems most
likely not to play a significant role.
Overall the evidence presented here, supports a number of theories regarding the divergent
phenotypes of EcNΔkfiC and EcNΔkfiB, but it is clear that further work will be required to
firmly establish the mechanisms through which loss of kfiB or kfiC lead to such different inter-
actions with IECs. In particular, the potential for wider aspects of cell physiology to be affected
by perturbation of K5 synthesis is suggested by the mutants characterised in this study. For ex-
ample, formation of elongated cells in JNBF17 point to an impact on regulation of broad as-
pects of cell replication and cell division. Therefore, the perturbation of K5 capsule
biosynthesis seems likely to have considerable impact on fundamental cellular processes, and
opens the potential for the observed effects on Caco-2 cell health to relate to disruption of
wider cellular functions, rather than aspects of K5 capsule assembly alone.
Nevertheless, our results reinforce the importance of the K5 capsule in facilitating the inter-
action between EcN and IECs, and indicate the potential for distinct differences in host-microbe
interaction to be mediated by modulation of K5 capsule production. This highlights the possi-
bility that alterations in capsule structure may govern a range of possible outcomes arising from
host-EcN interaction. Further studies, utilising a more definitive array of mutants in K5 biosyn-
thesis genes, stand to provide much fundamental insight into the mechanisms underpinning
the beneficial effects of EcN and its interaction with the host epithelium. Furthermore, as a
well-characterised probiotic with proven clinical effect, for which a broad array of robust genet-
ic tools are available, EcN is a prime candidate for the development of rational approaches to
probiotic design and tailored disease interventions. The results of this and subsequent studies
will contribute to the basic understanding required to underpin the rational design and devel-
opment of such tailored probiotic interventions, which hold much promise for the prophylaxis
of a variety of disorders, and the enhancement of human health.
Materials and Methods
Bacterial strains and cultures
E. coli Nissle 1917 wild-type (EcNWT) (Ardeypharm GmbH, Herdecke, Germany) and E. coli
K12 MG1655 wild-type (CGSC7740) were used in this study. E. coli BW29427, diamonopime-
lic acid auxotroph and:: pir (Datsenko KA and Wanner BL, Purdue University) served as the
mini-Tn5 donor strain. All strains were grown in Luria-Bertani (LB) (Fisher Scientific, UK) at
37°C with shaking. Media were supplemented with 50 μg ml–1 kanamycin (Km) for culture of
mini-Tn5 transposon donor strain, 30 μg ml–1 kanamycin and 100 nM diamonopimelic acid
(DAP) (Sigma-Aldrich, UK) for BW29427. Where appropriate the growth media was supple-
mented with 20 μg ml–1 chloramphenicol (Cm), 12 μg ml–1 tetracycline (Tc), or 200 μg ml–1
gentamicin (Gen) (Sigma, UK).
Random transposon mutagenesis
Mutants were generated from EcNWT with the pRL27::mini-Tn5 delivery system encoding a
hyperactive Tn5 transposase and carrying a mini-Tn5 element, essentially as described by Lar-
sen et al. [53]. Vector pRL27 was transferred to EcNWT from donor E. coli BW29427 by con-
jugal transfer. Mating experiments were performed with a donor/recipient ratio of 1/10, and
the mixed cultures incubated for 8 h at 37°C on LB agar plates supplemented with 100 nM
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DAP and 10 mMMgSO4. Trans-conjugant EcN colonies were selected and subsequently cul-
tured on LB agar supplemented with 50 μg ml–1 Km only. Mutants were stored in 96-well
plates at -80°C until required.
Loss of the pRL27 delivery vector and the presence of random, single mini-Tn5 chromo-
somal inserts were verified by analysis of restriction digest of plasmid extracts obtained using
the QIAprep Miniprep kit (Qiagen, UK), and Southern hybridisation with a mini-Tn5 specific
(DIG)-labelled probe. Probes were generated by PCR amplification of the mini-Tn5 nptII gene
with DIG-labelled dNTPs, components of the DIG luminescence detection kit for nucleic acids
(Roche, Burgess Hill, UK), using primers NPT2_F1/R1 (S2 Table).
Isolation of biofilm formation mutants
Mutants with altered biofilm forming abilities were isolated using the crystal violet (CV) stain-
ing-based assay based on that described by O’Toole and Kolter [54]. For the first screening
step, mutants were inoculated in 100 μl LB broth per well (in 96 well plates), sealed with plastic
films, and incubated statically at 37°C for 24 h. After incubation, cell cultures were decanted
and wells were washed twice with sterile deionised water (SDW) to remove non-adherent cells,
allowed to dry at room temperature (RT) for 5 min, then biofilms stained with 120 μl of a 1%
CV solution per well (Pro-Lab Diagnostics, Neston, UK) for 15 min at RT. Following removal
of excess CV, wells were washed three times with 150 μl sterile distilled water (SDW) to remove
excess stain, before elution of cell-bound CV by addition of 150 μl DMSO. Optical density was
then measured by spectrophotometry at 595 nm (OD595). The recorded readings were used to
calculate the average OD595 of all mutants per plate. To detect mutants with potential alter-
ations in biofilm formation, the pre-calculated average OD595 per plate was compared to indi-
vidual readings, and those showing +/- 0.1 of the plate OD595 average (Biofilm enhanced or
Biofilm deficient) were selected for the second-round screening.
The second screening step was performed to confirm the observed biofilm formation phe-
notypes of mutants isolated in first-round screens. The mutants were compared with the wild-
type EcN for biofilm formation in 96-well plate, again using the CV staining assay as described
above. For this screen, each plate contained wells inoculated with mutants (n = 4), the wild-
type (n = 4), and uninoculated LB broth (n = 4), and was performed in triplicate. Prior to the
biofilm staining, mutants were first assessed for their ability to grow as compared to the wild-
type. Growth was measured by spectrophotometry at 600 nm (OD600). Mutants showing statis-
tically significant differences in biofilm formation (at a P value 0.05), but without significant
differences in bacterial growth (P value> 0.05), were confirmed biofilm altered mutants and
defined as biofilm enhanced (BFE) or biofilm deficient (BFD) mutants. Mutants biofilm forma-
tion index was calculated as the percentage of CV (OD595) measured in the EcNWT.
Genetic characterisation of biofilm-altered mutants
Genes disrupted in mutants of interest were identified using a “cloning free” arbitrary PCR-
based approach to amplify DNA segments flanking the transposon insertion, as described by
Manoil [55] using primers listed in S2 Table. The resulting amplicons were sequenced by GATC
Biotech Ltd. (London, UK) using transposon end primer pLR27Primer 3. The putative function
of disrupted genes was assigned by mapping sequence data flanking the mini-Tn5 insert site to
the E. coliNissle Draft genomes sequence [28], and the previously published genomic islands
[29]. Sequence reads from mutants were trimmed to remove the 5’ low quality regions (typically
~30–50 nt), and the immediate ~40 nt flanking sections correlated with the EcN genome.
Where EcN genome annotations did not provide any clear indication of putative function wider
searches of the nr dataset using BlastX and/or the conserved domain database were employed.
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Construction of kfiB and kfiC deletion mutants
Deletion mutants EcNΔkfiB and EcNΔkfiC were constructed by homologous recombination
using the Xer-ciseTM chromosomal modification system (Cobra Biologics, Keele, UK) according
to manufacturer’s instructions and protocols described by Bloor and Cranenburgh [56]. The sys-
tem comprises plasmids pTOPO-DifCAT and pLGBE, for construction of target gene specific
integration cassette and provision of the Red λ recombination functions, respectively. Briefly,
kfiB or kfiC integration cassettes consisting of the difE. coli-cat-difE. coli region from
pTOPO-DifCAT plasmid flanked by 50 nt regions homologous to the 3’ and 5' ends of the target
gene, were generated by PCR using 70-nt primers, kfiB.int_F/R or kfiC.int_F/R (listed in S2
Table). EcNWTwas first transformed with the Tc-selectable plasmid pLGBE and transformants
EcN-pLGBE were used to generate electrocompetent cells, which were subsequently transformed
with the PCR product of the difE. coli-cat-difE. coli integration cassette constructs. Integrants were
selected on LB agar supplemented with 20 μg ml–1 Chloramphenicol. Loss of pLGBE and gener-
ation of chloramphenicol-sensitive clones, indicating resolution of difE. coli-cat-difE. colimarker
genes by native recombinases and generation of markerless deletion mutants (mutants EcNΔkfiB
and EcNΔkfiC) was achieved by sub-culturing the integrants in LB broth in the absence of anti-
biotics. Loss of pLGBE was verified by plasmid extraction, and by PCR for marker cassettes kfiB
or kfiC specific primers EcNkfiB _F/R or EcNkfiC _F/R, respectively, and confirmed by PCR.
Examination of polar effects in EcNΔkfiB and EcNΔkfiCmutants
The effect of gene deletion or disruptions in kfiB and kfiCmutants, on the expression of down-
stream genes (polar effects) was assessed using RT-PCR. Total RNA was extracted frommid-log-
phase bacterial cells using the RNeasy Protect Cell Mini Kit (Qiagen) according to manufactur-
er’s instructions, and treated using the Ambion TURBO DNA-free system (Ambion-Life tech-
nologies, Paisley, UK) to remove any potential DNA contamination. The treated RNA was used
to generate cDNA using the One Step RT-PCR kit (Qiagen) according to the manufacturer’s in-
structions, utilising 15 ng RNA per reaction as template. Resulting cDNA was used as template
in standard PCRs for detection of gene transcripts with specific primers detailed in S2 Table.
Confirmation of K5 capsule absence in EcNΔkfiB and EcNΔkfiCmutants
The K5 capsule-specific bacteriophage (FK5) [57] was used in this study to determine if the K5
capsule was expressed by EcNWT and deletion mutants. The bacteriophage was diluted and
maintained in phage dilution buffer (PDB) (100 mMNaCl, 8 mMMgSO4, 0.01% gelatine, 50
mM Tris pH 7.5). Cultures of mutants EcNΔkfiB and EcNΔkfiC, controls EcNWT and E.coli
MG1655 were grown in LB with shaking at 37°C to an OD600 of 0.3 then pelleted by centrifuga-
tion (10,000 × g for 10 min) and resuspended in ice-cold 10 mMMgSO4. Aliquots of cell sus-
pension (100 μl) were mixed with 100 μl of the appropriate bacteriophage dilution (ranging
from 101 to 109 PFU ml–1 from stock suspension of 2.1 × 109 PFU ml–1) in sterile 1.5 mL
Eppendorf tube then incubated at RT for 30 min, statically. The phage-bacteria mixture was
added to a volume of 3 ml of soft agar (1% NaCl, 0.5% yeast extract, 1% tryptone, 0.75% agar)
held at 42°C in 15 ml sterile glass tube, and the content of the tubes were mixed gently by swirl-
ing. The inoculated soft agar was poured on top of LB agar and incubated for 16 h at 37°C to
allow formation of plaques.
Intestinal epithelial cell culture and co-culture conditions
Caco-2 cells (passage 51–79) were grown at 37°C with 5% CO2 in Dulbecco's modified Eagle's
medium (DMEM, 4.5 g glucose l–1) supplemented with 10% fetal bovine serum and 1× non-
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essential amino acids (PAA Laboratories, Somerset, UK). Cells were seeded into 6-well or
96-well plates, grown up to ~ 60–80% confluence, and used in co-culture experiments with
bacteria. Mid-log-phase bacteria (OD600 of 0.5) were washed with PBS and suspended in
DMEM to the required final count, corresponding to the appropriate multiplicity of infection
(MOI) and added to Caco-2 monolayers before plates were incubated at 37°C and 5% CO2.
Bacterial adherence to Caco-2 cells
Adherence was calculated according to the strategy employed by Hafez et al. [18]. Mid-log
phase bacteria cultures were suspended in DMEM then added to monolayers of Caco-2 grown
in 6-well plates (80% confluence) at an MOI of 1:1 and incubated at 37°C and 5% CO2 for 4 h.
The monolayers were washed 3 times with PBS to remove non-adherent cells then treated with
lysis solution, 1% wt / vol saponin (Sigma Aldrich) in trypsin-EDTA (PAA Laboratories, Som-
erset, UK) for 10 min to allow permeabilisation of Caco-2 cells and recovery of total cell-associ-
ated bacteria. Cells were mixed gently by pipetting, serially diluted in sterile PBS, plated onto
LB agar, and incubated at 37°C overnight. The obtained viable count represented the total
number of cell associated bacteria (adherent and internalised). Internalised bacteria were calcu-
lated using the same protocol but Caco-2 cells were treated with gentamicin for 2h (200 μg ml-
1) to kill external bacteria prior to lysis and enumeration. The number of adherent bacteria was
taken as the difference between total cell associated bacteria and internalised bacteria.
The effect of EcN mutants on induction of apoptosis in Caco-2 cells
The effect of EcN mutants on induction of apoptosis Caco-2 cells was assessed by measuring
the activity of caspase 3/7 using the Caspase-Glo 3/7 kit (Promega, Southampton, UK), accord-
ing to manufacturer’s instructions. Cells were seeded in 96-well plates with 5,000 cells/well and
cultured to achieve ~ 60% confluence then treated with bacteria or bacterial supernatants in
co-culture. Media was replaced with serum-free DMEM for 12 h prior to the treatment. Bacte-
rial suspensions were prepared in serum-free DMEM from mid-log-phase cultures then added
to Caco-2 cells at an MOI of 10:1 (bacteria:Caco-2) in a final volume of 100 μl/ well. The plates
were incubated for 2 h at 37°C and 5% CO2 then media was replaced with fresh serum-free
DMEM supplemented with gentamicin at 200 μg ml–1 to stop bacterial growth, and plates were
incubated for another 10 h. Bacterial supernatants were obtained from cells grown in 5 mL
serum-free DMEM at 37°C overnight, with shaking, and recovered by centrifugation (1,500 × g
for 10 min), pH adjusted to 7.2, and filter-sterilised (0.2μm). The supernatants were diluted in
fresh serum-free DMEM at a ratio of 1:1, and used in place of cell suspensions as described
above. Caspase 3/7 activity was measured as relative light units (RLUs) using a Synergy Multi-
Mode Plate Reader (BioTek, Potton, UK) operated with BioTek Gen5.20 software.
Analysis of cytotoxicity
The effect of EcN strains on induction of cytotoxicity in Caco-2 cells was assessed by measur-
ing the amount of lactate dehydrogenase (LDH) released into the co-culture media, using the
CytoTox 96 Non-Radioactive Cytotoxicity Assay kit (Promega). Caco-2 cells were treated
with bacteria and controls as described for the analysis of apoptosis (above) and both assays
were performed in parallel. After treatment of Caco-2 cells, supernatants were collected from
plate wells using a multichannel pipette then transferred to fresh 96-well at 50 μl/well. The su-
pernatant was diluted further in serum-free culture media then mixed with the CytoTox 96
substrate at a ration of 1:1. Plates were incubated in the dark at room temperature for 30 min
and absorbance at 490 nm (OD490) was recorded. The percentage of cytotoxicity was calculat-
ed as LDH released in treated cells (OD490)/maximum LDH release (OD490) × 100. Maximum
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release was determined as the amount released by total lysis of untreated Caco-2 cells with the
CytoTox 96 lysis Solution (10X).
Analysis of cellular and nuclear morphology
Membrane integrity and nuclear morphology of Caco-2 cells were analysed by fluorescent
phalloidin (F-actin) and Dapi (DNA) stainings. Cells were grown on sterile glass cover slips in
6-well plates then treated with EcN strains and controls (MG1655 and 0.1 mM camptothecin;
Sigma) as described above (analysis of apoptosis). After the treatments, the cells on coverslips
were washed with PBS then fixed with 4% formaldehyde (Sigma) in PBS for 20 min at RT. The
fixed cells were washed three times with PBS and permeabilised with 0.1% Triton X-100
(Sigma) in PBS for 5 min at RT. The cells were washed three times with PBS, 5 min per wash
with gentle rocking, then treated with a 0.1 μg ml–1 solution of fluorescein isothiocyanate-phal-
loidin (Sigma- Aldrich) in PBS for 1 h at RT in the dark. The cells were washed twice with PBS
and were mounted with the Fluoroshield DAPI medium (Sigma) and examined under a Leica
TCS SP5 Confocal Laser Scanning microscope (Leica Microsystems, Wetzlar, Germany).
Analysis of COX-2 expression
The expression of COX-2 protein in Caco-2 co-cultures was analysed by western blotting
using standard methods. Briefly, Caco-2 cells were seeded in 6 wells plates, and at ~ 60% con-
fluence, were treated with EcN K5 mutants and controls as described above (analysis of apo-
ptosis). Lipopolysaccharide (LPS, final concentration, 5 μg ml–1) from Salmonella enterica
(Sigma, UK) and human tumour necrosis factor alpha (TNF-α, 10 ng ml–1) (Sigma, UK) were
used as pro-inflammatory stimulator positive controls. Treated Caco-2 cell monolayers were
washed 3 times with PBS, trypsinised then resuspended in 100 μl of hypotonic buffer (10 mM
HEPES, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT in SDW, pH 8.0), containing
Sigma protease inhibitor cocktail (1:20), for 15 min at 4°C. Cells were lysed in 25 μl 10% Tri-
ton X-100 for 30 min and total protein obtained by centrifugation (10,000 g for 1 min at 4°C).
Protein concentration was determined by the Bradford method (Bio-Rad) and equivalent
amounts of protein lysates (10 μg) separated by electrophoresis on SDS—PAGE (10%), and
then transferred onto a nitrocellulose membrane (GE Healthcare, Giles, UK). The blots were
blocked at RT with 10% skimmed milk powder in TBST buffer (10 mM Tris, pH 7.6, 0.5 M
NaCl, 0.05% Tween 20), and incubated with primary antibody, anti-COX-2 rabbit polyclonal
(Abcam, Cambridge, UK) 1:1,000 in TBST, overnight at 4°C. Blots were washed with TBST
then incubated with anti-rabbit HRP-conjugated secondary antibody (Sigma, UK) 1:5,000 in
TBST, for 1h at RT. Membranes were washed further then visualised by incubation with the
ECL chemiluminescent reagent (Amersham, Little Chalfont, UK) and exposed to Kodak
Image Station 440 for signal detection. Blots were then stripped and reprobed with loading
control anti-GAPDHmouse monoclonal (Ambion, Cambridge, UK); anti-mouse IgG HRP-
conjugated (Sigma, UK) as secondary antibody. The bands of COX-2 densitometry readings
were normalized to the GAPDH control.
Analysis of cell morphology and aggregation
Bacteria were grown statically in 5 mL LB in 50 mL sterile polystyrene tube at 37°C for 16 h.
The cultures were mix gently by swirling and 3 μL of each was directly transferred onto glass
slide, allowed to rest for 1 min then covered with a cover slip and visualised using ×40 magnifi-
cation phase contrast microscopy. For each culture 10 randomly selected fields of view across
each slide were captured using the Olympus Cell Sense software, and subsequently reviewed.
Representative images were selected and adjusted only for brightness and contrast.
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Statistical analysis
All statistical analysis was performed using Prism 6.0c For Mac OS X (Graphpad Software inc.
USA; www.graphpad.com). Data was analysed using either Student’s t-test, or ANOVA with
the Bonferroni correction for multiple comparisons.
Supporting Information
S1 Fig. Overview of K5 capsule biosynthesis in E. coli, and associated genes disrupted in
this study. Diagrams show the genetic organisation of the K5 gene cluster in E. coli Nissle 1917
based on data from Cress et al. [28]; Grozdanov et al. [29], and an overview of the current
model for K5 capsule biosynthesis and assembly adapted from Griffiths et al. [36]; Whitfield
[41]; Petit et al. [42]; Bliss et al. [43]; Hodson et al. [44]; Corbett and Roberts [45]; Whitfield
and Roberts [46]; Rigg et al. [47]; Whitfield and Willis [58]. A) Physical map of the EcN K5
capsular polysaccharide gene cluster. Region I (kpsF,E,D,U,C,S) and Region III (kpsM,T) en-
code elements of synthesis and export machinery, and are conserved among E. coli strains gen-
erating Group 2 polysaccharide capsules. Region II encodes K5 specific polysaccharide
synthesis machinery (kfiA,B,C,D). Genes disrupted by transposon mutagenesis (kfiB, kpsT)
and/or subject to gene knockout (kfiB,C) in this study are identified. HP—denote hypothetical
proteins of unknown function B) Representation of main stages and associated K5 biosynthetic
machinery (stages 1–3). K5 assembly is localised to the cytoplasmic face of the inner mem-
brane, and is underpinned by the formation of a biosynthetic complex which catalyses synthe-
sis and export polysaccharide precursors for incorporation in the maturing capsule on the cell
surface. During K5 assembly it is believed that a unified biosynthetic complex is developed
which progressively catalyses main stages [1–3]. However, for clarity here we have separated
each main stage of K5 synthesis and associated membrane complexes. Stage 1) Proteins en-
coded by kpsF,U,C,S are believed to be responsible for the initial generation of the phospatyidyl
acceptor and Kdo linker (keto-3-deoxy-manno-2-octulosonic acid), upon which the polysac-
charide chain is synthesised. Stage 2) Proteins encoded by kfiA-D are responsible for synthesis
of the polysaccharide chain through addition of alternating units of GlcA (glucuronic acid) and
GlcNAc (N-acetyl-glucosamine) from UDP-sugar precursors. Stage 3) Proteins generated by
kpsD,E,M,T form an ABC transporter complex that translocates completed polysaccharide
chains to the cell surface, in an energy dependant process.
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